Translating phage therapy into the clinic: Recent accomplishments but continuing challenges

• Aleksandra Petrovic Fabijan,

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  Affiliations Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Westmead, New South Wales, Australia, Faculty of Health and Medicine, School of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia

  ⨯
• Jonathan Iredell,

  Roles Writing – review & editing

  Affiliations Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Westmead, New South Wales, Australia, Faculty of Health and Medicine, School of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia, Westmead Hospital, Western Sydney Local Health District, Westmead, New South Wales, Australia

  ⨯
• Katarzyna Danis-Wlodarczyk,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Razieh Kebriaei,

  Roles Writing – original draft, Writing – review & editing

  Affiliation P3 Research Laboratory, College of Pharmacy, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Stephen T. Abedon

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  * E-mail: abedon.1@osu.edu

  Affiliation Department of Microbiology, The Ohio State University, Mansfield, Ohio, United States of America

  ⨯